Results 1 to 10 of about 190,239 (217)
Examining Discordance in Perceptions of COVID-19 and Influenza Vaccine Safety During Pregnancy Among a Cohort of US Adults [PDF]
VaccinesBackground/Objectives: Vaccination is an important strategy to protect pregnant people, fetuses, and infants from severe influenza and COVID-19. However, as of April 2025 in the United States, only 14% of pregnant women had received the 2024–2025 COVID ...
Rachael Piltch-Loeb +9 more
doaj +2 more sources
Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action [PDF]
VaccinesThe 8th meeting of the African Advisory Committee on Vaccine Safety (AACVS), constituted in 2021, convened by the Vaccine Research and Innovation Unit within the Vaccine Preventable Diseases Program, WHO Regional Office for Africa, was held virtually ...
Beckie N. Tagbo +11 more
doaj +2 more sources
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee [PDF]
Osong Public Health and Research Perspectives, 2023 With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events.
Na-Young Jeong +10 more
doaj +1 more source
Pharmaceuticals, 2023 In 2019, EMA licensed intravenous (IV) zanamivir for severe influenza virus infection in children over 6 months as well as adults. Prior to that, it was possible via a compassionate use program.
Maren Alchikh +3 more
doaj +1 more source
Viruses, 2022 Influenza virus (IV) coinfection, i.e., simultaneous infection with IV and other viruses, is a common occurrence in humans. However, little is known about the incidence and clinical impact of coinfection with two different IV subtypes or lineages (“dual ...
Patrick E. Obermeier +4 more
doaj +1 more source
Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022
Vaccines, 2023 Few analyses of COVID-19 vaccine attitudes also cover routine vaccines or focus on parents. In this cross-sectional study, we surveyed US adults in September 2022, immediately following the authorization of updated bivalent COVID-19 boosters for adults ...
Matthew Z. Dudley +4 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2023 Human umbilical cord mesenchymal stem cells (hUC-MSCs) are proposed for the treatment of acute lung injury and atopic dermatitis. To advance hUC-MSC entry into clinical trials, the effects of hUC-MSCs on the general toxicity, immune perturbation and ...
Wei Pan +25 more
doaj +1 more source
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea [PDF]
Osong Public Health and Research PerspectivesThe COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination.
Na-Young Jeong +14 more
doaj +1 more source
Identifying adverse reactions following COVID-19 vaccination in Korea using data from active surveillance: a text mining approach [PDF]
Epidemiology and HealthOBJECTIVES Unstructured text data collected through vaccine safety surveillance systems can identify previously unreported adverse reactions and provide critical information to enhance these systems.
Hye Ah Lee +11 more
doaj +1 more source
Medycyna Ogólna i Nauki o Zdrowiu, 2021 Introduction and objective COVID-19 disease, caused by the SARS-CoV-2 virus, has been recognised as a pandemic by WHO since 11 March 2020.
Przemysław Raczkiewicz +3 more
doaj +1 more source